Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
A Grisold, BC Callaghan… - Current Opinion in …, 2017 - journals.lww.com
A Grisold, BC Callaghan, EL Feldman
Current Opinion in Endocrinology, Diabetes and Obesity, 2017•journals.lww.comDPN is a chronic and disabling disease, and the accurate identification and modification of
DPN risk factors is important for clinical management. Recent data support a role for
components of the MetS and other risk factors in the development of DPN, offering novel
targets beyond hyperglycemia for therapeutic development.
DPN risk factors is important for clinical management. Recent data support a role for
components of the MetS and other risk factors in the development of DPN, offering novel
targets beyond hyperglycemia for therapeutic development.
Summary
DPN is a chronic and disabling disease, and the accurate identification and modification of DPN risk factors is important for clinical management. Recent data support a role for components of the MetS and other risk factors in the development of DPN, offering novel targets beyond hyperglycemia for therapeutic development.
Lippincott Williams & Wilkins